Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Open-Label Study to Evaluate Safety of A Single Dose of SYM-1219

ClinicalTrials.gov ID: NCT02452866

Public ClinicalTrials.gov record NCT02452866. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 3:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multi-center, Prospective, Open-Label Study to Evaluate the Safety of A Single Dose of SYM-1219, a Granule Formulation Containing 2 Grams of Secnidazole, for the Treatment of Women and Postmenarchal Adolescent Girls With Bacterial Vaginosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 3, multi-center, prospective, open-label study to evaluate the safety of SYM-1219 granules containing 2 grams of secnidazole in women and postmenarchal adolescent girls with bacterial vaginosis.

Study identification

NCT ID
NCT02452866
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Symbiomix Therapeutics
Industry
Enrollment
325 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2015
Primary completion
Sep 30, 2015
Completion
Sep 30, 2015
Last update posted
Apr 12, 2021

2015

United States locations

U.S. sites
40
U.S. states
21
U.S. cities
37
Facility City State ZIP Site status
Not listed Birmingham Alabama 35294
Not listed Phoenix Arizona 85018
Not listed Jonesboro Arkansas 72401
Not listed La Mesa California 91942
Not listed San Diego California 92108
Not listed Colorado Springs Colorado 80907
Not listed Denver Colorado 80209
Not listed Groton Connecticut 06340
Not listed Clearwater Florida 33759
Not listed Leesburg Florida 34748
Not listed Miami Florida 33186
Not listed North Miami Florida 33161
Not listed Plantation Florida 33324
Not listed Wellington Florida 33414
Not listed Atlanta Georgia 30312
Not listed Columbus Georgia 31904
Not listed Roswell Georgia 30075
Not listed Shawnee Mission Kansas 66218
Not listed Baltimore Maryland 21224
Not listed Fall River Massachusetts 02720
Not listed Grand Rapids Michigan 49503
Not listed Kalamazoo Michigan 49009
Not listed Saginaw Michigan 48604
Not listed Plainsboro New Jersey 08536
Not listed New Bern North Carolina 28562
Not listed Winston-Salem North Carolina 27103
Not listed Columbus Ohio 43213
Not listed Columbus Ohio 43231
Not listed Philadelphia Pennsylvania 19107
Not listed Philadelphia Pennsylvania 19114
Not listed Myrtle Beach South Carolina 29572
Not listed Jackson Tennessee 38305
Not listed Corpus Christi Texas 78414
Not listed Dallas Texas 75231
Not listed Houston Texas 77054
Not listed San Antonio Texas 78229
Not listed Norfolk Virginia 23507
Not listed Virginia Beach Virginia 23456
Not listed Seattle Washington 98104
Not listed Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02452866, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 12, 2021 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02452866 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →